KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Total Non-Current Liabilities (2017 - 2025)

Elanco Animal Health's Total Non-Current Liabilities history spans 9 years, with the latest figure at -$427.0 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 106.87% year-over-year to -$427.0 million; the TTM value through Dec 2025 reached -$427.0 million, down 106.87%, while the annual FY2025 figure was -$427.0 million, 106.87% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was -$427.0 million at Elanco Animal Health, down from $6.2 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $8.7 billion in Q1 2021 and bottomed at -$7.1 billion in Q3 2024.
  • The 5-year median for Total Non-Current Liabilities is $7.8 billion (2023), against an average of $6.1 billion.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 4452.46% in 2023 before it tumbled 191.41% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $8.7 billion in 2021, then dropped by 8.19% to $8.0 billion in 2022, then dropped by 3.07% to $7.7 billion in 2023, then dropped by 19.57% to $6.2 billion in 2024, then plummeted by 106.87% to -$427.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Total Non-Current Liabilities are -$427.0 million (Q4 2025), $6.2 billion (Q3 2025), and $6.3 billion (Q2 2025).